These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 33757890)
21. Bridging-therapy with intravenous recombinant tissue plasminogen activator improves functional outcome in patients with endovascular treatment in acute stroke. Maier IL; Behme D; Schnieder M; Tsogkas I; Schregel K; Kleinknecht A; Wasser K; Bähr M; Knauth M; Psychogios M; Liman J J Neurol Sci; 2017 Jan; 372():300-304. PubMed ID: 28017233 [TBL] [Abstract][Full Text] [Related]
22. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451 [TBL] [Abstract][Full Text] [Related]
23. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. Yang P; Zhang Y; Zhang L; Zhang Y; Treurniet KM; Chen W; Peng Y; Han H; Wang J; Wang S; Yin C; Liu S; Wang P; Fang Q; Shi H; Yang J; Wen C; Li C; Jiang C; Sun J; Yue X; Lou M; Zhang M; Shu H; Sun D; Liang H; Li T; Guo F; Ke K; Yuan H; Wang G; Yang W; Shi H; Li T; Li Z; Xing P; Zhang P; Zhou Y; Wang H; Xu Y; Huang Q; Wu T; Zhao R; Li Q; Fang Y; Wang L; Lu J; Li Y; Fu J; Zhong X; Wang Y; Wang L; Goyal M; Dippel DWJ; Hong B; Deng B; Roos YBWEM; Majoie CBLM; Liu J; N Engl J Med; 2020 May; 382(21):1981-1993. PubMed ID: 32374959 [TBL] [Abstract][Full Text] [Related]
24. Clinical Outcomes of On-Site Versus Off-Site Endovascular Stroke Interventions. Alkhouli M; Alqahtani F; Hopkins LN; Harris AH; Hohmann SF; Tarabishy A; Holmes DR JACC Cardiovasc Interv; 2020 Sep; 13(18):2159-2166. PubMed ID: 32861630 [TBL] [Abstract][Full Text] [Related]
25. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384 [TBL] [Abstract][Full Text] [Related]
26. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment. Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS; Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995 [TBL] [Abstract][Full Text] [Related]
27. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Baxter BW; Devlin TG; Lopes DK; Reddy VK; du Mesnil de Rochemont R; Singer OC; Jahan R; N Engl J Med; 2015 Jun; 372(24):2285-95. PubMed ID: 25882376 [TBL] [Abstract][Full Text] [Related]
28. Developing a multivariable prediction model for functional outcome after reperfusion therapy for acute ischaemic stroke: study protocol for the Targeting Optimal Thrombolysis Outcomes (TOTO) multicentre cohort study. Holliday E; Lillicrap T; Kleinig T; Choi PMC; Maguire J; Bivard A; Lincz LF; Hamilton-Bruce MA; Rao SR; Snel MF; Trim PJ; Lin L; Parsons MW; Worrall BB; Koblar S; Attia J; Levi C BMJ Open; 2020 Apr; 10(4):e038180. PubMed ID: 32265253 [TBL] [Abstract][Full Text] [Related]
29. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study. Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677 [TBL] [Abstract][Full Text] [Related]
30. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation. Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of reperfusion therapy for acute ischaemic stroke in patients aged 90 years or older: a retrospective study. Gomes C; Barcelos V; Guiomar V; Pintalhão M; Almeida J; Fonseca L Intern Emerg Med; 2021 Jan; 16(1):101-108. PubMed ID: 32248402 [TBL] [Abstract][Full Text] [Related]
32. The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis. Gadalean F; Simu M; Parv F; Vorovenci R; Tudor R; Schiller A; Timar R; Petrica L; Velciov S; Gluhovschi C; Bob F; Mihaescu A; Timar B; Spasovski G; Ivan V PLoS One; 2017; 12(10):e0185589. PubMed ID: 29040276 [TBL] [Abstract][Full Text] [Related]
33. Clinical features and efficacy of reperfusion therapy in minor ischemic stroke patients with atrial fibrillation. Nomura E; Takemaru M; Himeno T; Kono R; Fukushima T; Ota S J Thromb Thrombolysis; 2020 Oct; 50(3):608-613. PubMed ID: 32048168 [TBL] [Abstract][Full Text] [Related]
34. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke? Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555 [TBL] [Abstract][Full Text] [Related]